Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...
Bullish option flow detected in Moderna (MRNA) with 25,737 calls trading, 1.2x expected, and implied vol increasing almost 4 points to 82.07%. Jan-26 35 calls and 3/7 weekly 35 calls are the most ...
In a report released yesterday, Harry Gillis from Berenberg Bank maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $30.00. See what stocks are receiving Strong ...
The Treasury Department has announced that it will no longer enforce the Corporate Transparency Act or the associated BOI reporting requirements. The Treasury Department has announced that it will ...
Moderna Inc.’s stock erased early losses to gain more than 3% on Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting ...
Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. President Donald Trump’s first month in office has been dizzying for U.S ...
Feb 28 (Reuters) - Britain's health regulator said on Friday it has approved Moderna's (MRNA.O), opens new tab vaccine for respiratory syncytial virus in adults 60 years and older. The shot ...
(Bloomberg) -- US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to Moderna Inc., people familiar with the matter said.
HHS cites need for review due to 'oversight' issues CDC states low risk of H5 bird flu to public Moderna's shares drop 5.5% Feb 26 (Reuters) - U.S. health officials are reevaluating a $590 million ...
Byrd also said noncompliance flourished due to the administration's lack of transparency with the school board and the public. The state auditor's office reviewed 37.7 million in TPS expenditures ...
The most recent hospital price transparency compliance report from the nonprofit PatientRightsAdvocate.org, published in November 2024, found that only 21.1 percent of hospitals that were reviewed ...
Trump Administration Weighs Pulling Funding for Moderna Bird Flu Vaccine, Bloomberg News Reports (Reuters) - U.S. health officials are reevaluating a $590 million contract that was awarded to ...